MK6-83 is primarily investigated for its potential as a selective inhibitor of specific kinases involved in inflammatory and oncogenic signaling pathways. It has shown promise in preclinical studies for targeting diseases driven by aberrant kinase activity, particularly in certain types of cancer. Its application lies in the development of targeted therapies where it can suppress tumor cell proliferation and induce apoptosis with minimal impact on healthy cells. Due to its selectivity and potency, MK6-83 is also used as a research tool to study kinase-dependent cellular processes and to validate new therapeutic targets in drug discovery.